FDA clearance for Stealth AXiS™, PMA approval for Infuse™ TLIF, and a strong Q3 earnings beat set the stage for what ...

Medtronic (NYSE:MDT) announced today that it received FDA clearance for its Stealth AXiS robotic system for spine surgery.

Called Stealth AXiS, the surgical system builds on Medtronic’s Mazor robotic platform, as the medical device maker takes ...

The Stealth AXiS system architecture allows support for a variety of surgeon preferences and clinical complexities.

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) ...

Medtronic receives FDA clearance Stealth AXiS, first integrated planning, navigation and robotics platform for spine surgery ...

The Stealth AXiS™ system has received regulatory clearance as the first platform to natively unify AI-driven planning and robotic execution for spinal procedures. 2. Real-time segmental tracking ...

FDA’s clearance of Medtronic’s Stealth Axis surgical system comes on the heels of the company winning a nod for the Hugo ...

Medtronic built the Stealth AXiS system to support a wide range of surgeon preferences, clinical complexity, and care settings.

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced U.S. Food and Drug Administration (FDA) clearance of the Stealth ...